KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolent Health (EVH) Invested Capital (2016 - 2025)

Evolent Health (EVH) has 11 years of Invested Capital data on record, last reported at $847.4 million in Q3 2025.

  • For Q3 2025, Invested Capital fell 18.42% year-over-year to $847.4 million; the TTM value through Sep 2025 reached $847.4 million, down 18.42%, while the annual FY2024 figure was $1.2 billion, 9.84% up from the prior year.
  • Invested Capital reached $847.4 million in Q3 2025 per EVH's latest filing, down from $1.1 billion in the prior quarter.
  • Across five years, Invested Capital topped out at $1.2 billion in Q4 2024 and bottomed at $611.2 million in Q1 2022.
  • Average Invested Capital over 5 years is $908.9 million, with a median of $1.0 billion recorded in 2024.
  • The widest YoY moves for Invested Capital: up 223.29% in 2021, down 43.7% in 2021.
  • A 5-year view of Invested Capital shows it stood at $693.6 million in 2021, then increased by 23.9% to $859.4 million in 2022, then increased by 24.24% to $1.1 billion in 2023, then grew by 9.84% to $1.2 billion in 2024, then dropped by 27.75% to $847.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Invested Capital were $847.4 million in Q3 2025, $1.1 billion in Q2 2025, and $1.1 billion in Q1 2025.